An Australian entrepreneur has launched a startup named Gamgee, aiming to develop personalized mRNA cancer vaccines for dogs and eventually humans. The company's origin story involves using AI tools like ChatGPT and Grok to create a vaccine for the founder's dog, Rosie, which he claims extended her life. However, the scientific attribution of Rosie's improvement solely to the AI-designed vaccine has been questioned, with researchers noting the complexity of the intervention and the potential overstatement of AI's role. Despite these questions, Gamgee has secured backing from Y Combinator and is initiating clinical trials in Australia. AI
IMPACT Highlights the potential for AI in personalized medicine, but also the need for rigorous scientific validation and clear attribution.
RANK_REASON Startup launch based on a questionable AI application.
Read on Mastodon — fosstodon.org →
- ChatGPT
- Gamgee
- Grok
- Paul Conyngham
- Rosie
- The Verge
- University of New South Wales
- University of Queensland
- Y Combinator
AI-generated summary · Google Gemini · from 3 sources. How we write summaries →
